Pro Medicus Ltd
XMUN:PMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pro Medicus Ltd
XMUN:PMC
|
AU |
|
Central Pattana PCL
OTC:CPPBY
|
TH |
Intrinsic Value
The intrinsic value of 
Pro Medicus Ltd (PMC) under the Base Case is 1.52 EUR per share.
Compared with the current market price of 10.6 EUR, the stock appears
Overvalued by 86% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Pro Medicus Does
Pro Medicus makes medical imaging software for hospitals, radiology groups, and other healthcare providers. Its main product is Visage, a system that helps doctors store, view, share, and interpret scans such as X-rays, CTs, and MRIs on fast digital workstations and cloud-based setups. The company does not sell medical devices or run clinics; it sells software that sits in the workflow between imaging equipment and the clinicians who read the images.
- Headquarters
- Australia AU
- Employees
- 132
- IPO date
- Oct 10, 2000
Pro Medicus has a wide economic moat
Patented image-streaming technology lets hospitals view medical scans quickly while using less hardware than many competing systems. Once Pro Medicus software is connected to a hospital’s image archives and clinical workflows, moving to another provider can require substantial data transfer and rebuilding work.
Read the full moat analysis
Earnings Waterfall
Pro Medicus Ltd
The intrinsic value for Pro Medicus Ltd (PMC) under the Base Case is 1.52 EUR.
Compared with the current market price of 10.6 EUR, the stock appears Overvalued by 86% .